The new biomarker to diagnose heart failure
| Project/Area Number |
21590886
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Circulatory organs internal medicine
|
|---|
| Research Institution | Chiba University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2009: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | 心不全 / 虚血性心疾患 / 心腎連関 / 左室リモデリング / 血中マーカー |
|---|
| Research Abstract |
To evaluate the factors to detect the prognosis of the patients with heart failure, blood samples, clinical factors and medicine were screened. The anti-p53 antibody was not related to the severity of the heart failure. The prescription of telmisartan was related to the inhibitory effects on the progression of intima-media thickness of the carotid artery wall. The prescription of candesartan was related to the inhibitory effects on the morning hypertension, which was one of the risk factors of cardiovascular mortality.
|
Report
(4 results)
Research Products
(40 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Effect of Pitavastatin on Pressure2012
Author(s)
Yoshihito Kameda, Hiroshi Hasegawa, Akihiko Kubota, Hiroyuki Tadokoro, Yoshio Kobayashi, Hiroyuki Takano
Organizer
Overload-Induced Heart Failure in Mice American College of Cardiology 2012
Place of Presentation
米国シカゴ
Year and Date
2012-03-26
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
